Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T3VF
|
|||
| Drug Name |
GSK3050002
|
|||
| Indication | Psoriatic arthritis [ICD-11: FA21; ICD-9: 696] | Phase 1 | [1] | |
| Company |
GlaxoSmithKline Research Triangle Park, NC
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver and activation-regulated chemokine (CCL20) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.